Kidswell Bio Corporation (TYO:4584)
245.00
-3.00 (-1.21%)
At close: Feb 6, 2026
Kidswell Bio Revenue
Kidswell Bio had revenue of 1.56B JPY in the quarter ending September 30, 2025, with 22.76% growth. This brings the company's revenue in the last twelve months to 6.61B, up 321.22% year-over-year. In the fiscal year ending March 31, 2025, Kidswell Bio had annual revenue of 5.08B with 223.90% growth.
Revenue (ttm)
6.61B
Revenue Growth
+321.22%
P/S Ratio
1.84
Revenue / Employee
178.62M
Employees
37
Market Cap
12.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.08B | 3.51B | 223.90% |
| Mar 31, 2022 | 1.57B | 573.00M | 57.53% |
| Mar 31, 2021 | 996.00M | -81.00M | -7.52% |
| Mar 31, 2020 | 1.08B | 55.30M | 5.41% |
| Mar 31, 2019 | 1.02B | -38.02M | -3.59% |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CellSource | 3.71B |
| StemCell Institute | 2.72B |
| ReproCELL | 2.63B |
| Immuno-Biological Laboratories | 1.01B |
| MEDINET | 998.00M |
| Stella Pharma | 992.00M |
| CellSeed | 161.00M |
| Nano Holdings | 142.00M |